Amyloid initiates this process, which is followed by a variety of neurobiological processes, including tau pathology, brain atrophy and synaptic dysfunction, initially with a slight cognitive decline, followed by memory impairment, aphasia, visual–spatial skills impairment, executive dysfunction, personality and behavioral changes (Aisen et al., 2022). The gene discussed is MAPT; the disease is Mental deterioration.